Home > Market Research > Hospital Markets > Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US

Table of Contents

Management Report
Published: September 2008
Pages: 100
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 657.89   Buy Now!
Research from: RNCOS
Sector: Hospital Markets

The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world. And according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, the new research report from RNCOS, the potential and opportunities in this market are expected to increase several fold in the next five years.

This report provides factual insight supplemented with statistical overview on the past, present and future market. It studies the entire structure, composition and working of the US healthcare sector and describes the potential of hospital services, pharmaceuticals and medical devices in the market. This report discusses the demand, market size and future prospects of nearly every major sector, like cardiovascular, diabetes, musculoskeletal, oncology, wound care management, cosmetic surgery, dental health, and in vitro diagnostics, in the US healthcare market. It identifies key opportunities and roadblocks that will affect the future direction of the market.

“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” thus serves as a guide for healthcare service providers/drug manufactures/investors who are planning to enter the US healthcare market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles.

Key Findings of the Report

§ Total healthcare spending in the US is expected to grow at a CAGR of 7% between 2007 and 2012.
§ Around 43 Million people are expected to be above 65 years of age in the US by 2012, thereby increasing the prevalence of several chronic diseases.
§ Around 122 Million Americans are expected to suffer from cardiovascular diseases by 2012, leading to direct expenses of over US$ 414 Billion.
§ The US, with over 19 Million diabetics by 2012, is expected to fuel the growth of the diabetes drugs and monitoring devices market.
§ Driven by target-based therapies with negligible side effects, the US oncology market is amongst the fastest growing sectors in the healthcare industry.
§ The aging baby boomers, coupled with an increasing incidence of hip and knee fractures, are expected to strongly drive the musckoskeletal market.
§ Driven by a need to look young and attractive, both surgical and non-surgical cosmetic procedures are becoming highly popular.

Key Issues & Facts Analyzed in the Report

§ Evaluation of past, current and future market trends.
§ Market evaluation by type of disease.
§ Discussion on the major drivers of the healthcare market.
§ Identification and evaluation of the opportunities created by the market.
§ Analysis of major challenges for the market.

Research Methodology Used in the Report

Information Sources
Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.

Analysis Methods
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.

Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.

Top of Page

Table of Contents

1. Analyst View
2. The US Healthcare Industry
2.1 Source of Funding
2.1.1 Public Coverage
2.1.2 Private Coverage
2.2 Healthcare Outlay
3. What Makes the Market Lucrative?
3.1 High Expenditure on Healthcare
3.2 Aging Population
3.3 Increasing Obesity
3.4 Technological Advancements
4. Healthcare Indicators & Demographics
4.1 Population & Demographics
4.2 Hospitals & Healthcare Professionals
4.3 Mortality & Leading Causes of Death
5. Analysis by Type of Disease To 2012
5.1 Cardiovascular
5.1.1 Facts & Figures
5.1.2 Market Analysis
5.2 Diabetes
5.2.1 Facts & Figures
5.2.2 Market Analysis
5.3 Oncology
5.3.1 Facts & Figures
5.3.2 Market Analysis
5.4 Musckoloskeletal Market
5.4.1 Facts & Figures
5.4.2 Market Analysis
5.5 Wound Care Management
5.5.1 Facts & Figures
5.5.2 Market Analysis
5.6 Cosmetic Surgery
5.6.1 Facts & Figures
5.6.2 Market Analysis
5.7 HIV
5.7.1 Facts & Figures
5.7.2 Market Analysis
5.8 Dental Health
5.8.1 Facts & Figures
5.8.2 Market Analysis
5.9 IVD
5.9.1 Market Analysis
6. Industry Roadblocks
6.1 Stringent Regulations
6.2 Large Uninsured Population
6.3 Medical Tourism

List of Figures:

Figure 2-1: US - Healthcare Expenditure (in Billion US$), 2001-2007E
Figure 2-2: US - Forecast for Healthcare Expenditure (in Billion US$), 2008-2012
Figure 2-3: US - Healthcare Expenditure by Source of Funding (%), 2006
Figure 2-4: US - Healthcare Expenditure by Type of Service (%), 2006
Figure 3-1: US - Population Aged 65 Years & Above (in Million), 2001-2007 & 2012F
Figure 3-2: US - Number of Baby-boomers Living with Chronic Conditions (in Million), 2000, 2010F & 2020F
Figure 3-3: US - Annual Healthcare Cost per Person by Number of Chronic Conditions (in US$)
Figure 3-4: US - Prevalence of Obesity* among Adults** (%), 1995, 2000, 2005 & 2012F
Figure 4-1: US - Population (in Million), 2001-2007
Figure 4-2: US - Forecast for Population (in Million), 2008*-2012
Figure 4-3: US - Population Breakup by Age Group (%), 2001-2007
Figure 4-4: US - Forecast for Population Breakup by Age Group (%), 2008*-2012
Figure 4-5: US - Number of Community Hospitals (1981, 1991, 2001 & 2006)
Figure 4-6: US - Hospital Admissions by Boomers & Non-boomers (in Million), 2004, 2010F, 2020F & 2030F
Figure 4-7: US - Physician Office Visits by Boomers & Non-boomers (in Million), 2004, 2010F, 2020F & 2030F
Figure 4-8: US - Hospital Admissions by Age (%), 2004 & 2030F
Figure 4-9: US - Hospital Revenues by Inpatients & Outpatients (%), 1981, 1991, 2001 & 2005
Figure 4-10: US - Hospital Surgeries by Inpatients & Outpatients (%), 1981, 1991, 2001 & 2005
Figure 4-11: US - Share of Healthcare Employment in Total Employment (%), 2006
Figure 4-12: US - Number of Doctors (1990, 1995, 2000 & 2003 to 2007E)
Figure 4-13: US - Number of Dentists (1990, 1995, 2000 & 2003 to 2007E)
Figure 4-14: US - Number of Nurses (1990, 1995, 2000 & 2003 to 2007E)
Figure 4-15: US - Supply & Demand of Primary Care Physicians* (in ‘000), 2000, 2005, 2010F, 2015F & 2020F
Figure 4-16: US - Shortage of Specialists* (in ‘000), 2005, 2010F, 2015F & 2020F
Figure 4-17: US - Breakup of Leading Causes of Death (%), 2005
Figure 4-18: US - Number of Deaths due to Leading Causes (in ‘000), 2005
Figure 4-19: US - Forecast for Breakup of Leading Causes of Death (%), 2030
Figure 4-20: US - Forecast for Number of Deaths due to Leading Causes (in ‘000), 2030
Figure 5-1: US - Deaths by Type of Cardiovascular Disease (%), 2004
Figure 5-2: US - Diabetic Patients* (in ‘000), 2003. 2007E, 2012F & 2025F
Figure 5-3: US - Diabetes Drug Market (in Billion US$), 2000-2007E & 2012F
Figure 5-4: US - Breakup of OADs & Insulin in Diabetes Drug Market (%), 2000-2007E & 2012F
Figure 5-5: US - Insulin Market (in Billion US$), 2000-2007E & 2012F
Figure 5-6: US - Insulin Delivery Market (in Billion US$), 2004, 2007E & 2012F
Figure 5-7: US - Insulin Delivery Market by Type of Device (%), 2004
Figure 5-8: US - Oral Anti-diabetic Market (in Billion US$), 2000-2007E & 2012F
Figure 5-9: US - Blood Glucose Testing Market (in Billion US$), 2004, 2007E & 2012F
Figure 5-10: US - Blood Glucose Testing Market by Type of Product (%), 2004
Figure 5-11: US - Estimated Number of New Cancer Cases (2005, 2008 & 2012)
Figure 5-12: US - Cancer Market (in Billion US$), 1999, 2004, 2007E & 2012F
Figure 5-13: US - Breakup of Cancer Market by Therapy (%), 1999, 2004, 2007E & 2012F
Figure 5-14: US - Chemotherapy Market (in Billion US$), 1999, 2004, 2007E & 2012F
Figure 5-15: US - Cancer Surgery Market (in Billion US$), 1999, 2004, 2007E & 2012F
Figure 5-16: US - Radiation Therapy Market (in Billion US$), 1999, 2004, 2007E & 2012F
Figure 5-17: US - Biotechnology-based Cancer Drug Market (in Billion US$), 1999, 2004, 2007E & 2012F
Figure 5-18: US - Cancer Diagnostic Market (in Billion US$), 2006 & 2012F
Figure 5-19: US - Osteoporosis & Low Bone Mass Patients (in Million), 2007, 2010F & 2020F
Figure 5-20: US - Osteoporosis-related Fractures per Annum (%)
Figure 5-21: US - Knee Replacement Procedures* (in Number), 2000-2007E & 2012F
Figure 5-22: US - Hip Replacement Procedures* (in Number), 2000-2007E & 2012F
Figure 5-23: US - Musculoskeletal Device & Implant Market (in Billion US$), 2002, 2004, 2005, 2008F & 2012F
Figure 5-24: US - Musculoskeletal Device & Implant Market by Segment (%), 2008
Figure 5-25: US - Orthopedic Reconstructive Device Market by Segment (%), 2008
Figure 5-26: US - Fixation Market by Segment (%), 2008
Figure 5-27: US - Spinal Product Market by Segment (%), 2008
Figure 5-28: US - Number of Wounds & Wounds Treated with Active & Advanced Wound Care Products (in Million), 2005
Figure 5-29: US - Wound Care Product Market (in Million US$), 2001, 2003, 2005E, 2007E, 2009F & 2012F
Figure 5-30: US - Surgical & Non-surgical Cosmetic Procedures (in ‘000), 1997 & 2004-2007
Figure 5-31: US - Federal Expenditure on HIV/AIDS (in Billion US$), 2006-2009F
Figure 5-32: US - Forecast for Breakup of Federal Expenditure on HIV/AIDS (%), 2009
Figure 5-33: US - Antiretroviral Market Dynamics (in ‘000)
Figure 5-34: US - Antiretroviral Market (in Billion US$), 2004, 2007E & 2012F
Figure 5-35: US - Share of Key Players in Antiretroviral Market (%), 2004
Figure 5-36: US - Expenditure on Dental Services (in Million US$), 2000-2007E & 2012F
Figure 5-37: US - IVD Market (in Billion US$), 2006 & 2007E
Figure 5-38: US - IVD Market* by Segment (%), 2007E
Figure 5-39: US - Forecast for IVD Market (in Billion US$), 2008-2012
Figure 6-1: US - Uninsured People (in Million), 2005-2007E

List of Tables:

Table 2-1: US - Public Healthcare Expenditure by Source of Funding (in Million US$), 2001-2006
Table 2-2: US - Private Healthcare Expenditure by Source of Funding (in Million US$), 2001-2006
Table 2-3: US - Healthcare Expenditure by Type of Service (in Billion US$), 2001-2006
Table 3-1: US - Healthcare Expenditure (in Billion US$) & Healthcare Expenditure as a % of GDP w.r.t. Various Developed Countries (2007)
Table 5-1: US - Prevalence of Various Cardiovascular Diseases (in Million), 2002, 2005, 2007E & 2012F
Table 5-2: US - Number of Various Cardiovascular Procedures (2001, 2005 & 2012F)
Table 5-3: US - Cost & In-hospital Death Rates of Various Cardiovascular Procedures (2004)
Table 5-4: US - Cardiovascular Diseases & Stroke Expenditure by Type (in Billion US$), 2008E
Table 5-5: US - Forecast for Cardiovascular Diseases & Stroke Expenditure by Type (in Billion US$), 2012
Table 5-6: US - Diabetic Patients in Age Group of 20-79 Years (in ‘000), 2003
Table 5-7: US - Forecast for Diabetic Patients in Age Group of 20-79 Years (in ‘000), 2025
Table 5-8: US - Estimated Number of New Cancer Cases for Selected Cancer Sites (2008)
Table 5-9: US - Musculoskeletal Device & Implant Market by Segment (in Million US$), 2002, 2004, 2005 & 2008E
Table 5-10: US - Wound Care Product Market by Segment (in Million US$), 2001, 2003, 2005E, 2007E, 2009F & 2010F
Table 5-11: US - Key Facts related to Surgical Cosmetic Procedures
Table 5-12: US - Key Facts related to Non-surgical Cosmetic Procedures
Table 5-13: US - Per Procedure Physician Fees & Expenditure on Various Surgical Cosmetic Procedures (in US$), 2007
Table 5-14: US - Statistics of Various Surgical Cosmetic Procedures (2007)
Table 5-15: US - Per Procedure Physician Fees & Expenditure on Various Non-surgical Cosmetic Procedures (in US$), 2007
Table 5-16: US - Statistics of Various Non-surgical Cosmetic Procedures (2007)
Table 5-17: US - Number of Top 5 Male & Female Cosmetic Procedures (in ‘000), 2007
Table 5-18: US - AIDS Diagnosis & Deaths (in Number), 2002-2006
Table 5-19: US - Dental Equipment & Supplies Market (in Million US$), 1993, 1998, 2003, 2008E & 2013F
Table 5-20: US - Dental Procedures & Visits (in Million), 1993, 1998, 2003, 2008E & 2013F
Table 6-1: US - Cost of Various Surgical Procedures w.r.t. Other Countries (in US$)

For full details, please email keithw@cmsinfo.com

Top of Page

Buy now!

Single user PDF

 GBP 657.89   

Multi-User License

 GBP 921.05   

Hard copy

 GBP 789.47   

CD-Rom

 GBP 789.47   

Your personal guarantee

Top of Page